dc.creator | Folch J. | |
dc.creator | Busquets O. | |
dc.creator | Ettcheto M. | |
dc.creator | Sánchez-López E. | |
dc.creator | Castro-Torres R.D. | |
dc.creator | Verdaguer E. | |
dc.creator | Garcia M.L. | |
dc.creator | Olloquequi J. | |
dc.creator | Casadesús G. | |
dc.creator | Beas-Zarate C. | |
dc.creator | Pelegri C. | |
dc.creator | Vilaplana J. | |
dc.creator | Auladell C. | |
dc.creator | Camins A. | |
dc.date.accessioned | 2020-09-02T22:17:53Z | |
dc.date.accessioned | 2022-11-08T20:23:45Z | |
dc.date.available | 2020-09-02T22:17:53Z | |
dc.date.available | 2022-11-08T20:23:45Z | |
dc.date.created | 2020-09-02T22:17:53Z | |
dc.date.issued | 2018 | |
dc.identifier | 62, 3, 1223-1240 | |
dc.identifier | 13872877 | |
dc.identifier | https://hdl.handle.net/20.500.12728/4488 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5144980 | |
dc.language | en | |
dc.publisher | IOS Press | |
dc.subject | Alzheimer's disease | |
dc.subject | Amyloid-protein | |
dc.subject | Extrasynaptic N-Methyl-D-aspartate receptor | |
dc.subject | Memantine | |
dc.subject | Tau protein | |
dc.subject | amyloid | |
dc.subject | apoenzyme | |
dc.subject | brain derived neurotrophic factor | |
dc.subject | cyclin dependent kinase 5 | |
dc.subject | memantine | |
dc.subject | n methyl dextro aspartic acid receptor | |
dc.subject | synapse receptor | |
dc.subject | memantine | |
dc.subject | neuroprotective agent | |
dc.subject | Alzheimer disease | |
dc.subject | clinical feature | |
dc.subject | clinical trial (topic) | |
dc.subject | dementia | |
dc.subject | diabetes mellitus | |
dc.subject | drug effect | |
dc.subject | drug efficacy | |
dc.subject | drug treatment failure | |
dc.subject | human | |
dc.subject | inflammation | |
dc.subject | insulin metabolism | |
dc.subject | modulation | |
dc.subject | multicenter study (topic) | |
dc.subject | neurofibrillary tangle | |
dc.subject | nonhuman | |
dc.subject | oxidative stress | |
dc.subject | pathology | |
dc.subject | pathophysiology | |
dc.subject | phase 3 clinical trial (topic) | |
dc.subject | preclinical study | |
dc.subject | priority journal | |
dc.subject | protein phosphorylation | |
dc.subject | randomized controlled trial (topic) | |
dc.subject | Review | |
dc.subject | Alzheimer disease | |
dc.subject | animal | |
dc.subject | metabolism | |
dc.subject | Alzheimer Disease | |
dc.subject | Animals | |
dc.subject | Humans | |
dc.subject | Memantine | |
dc.subject | Neuroprotective Agents | |
dc.title | Memantine for the treatment of dementia: A review on its current and future applications | |
dc.type | Review | |